- At the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2022 Annual Meeting, GE Healthcare proudly showcases cutting-edge solutions spanning the care continuum and enabling theranostics in prostate cancer
- This includes a new cyclotron Solid Target Platform which increases Gallium-68 production and access – a radioisotope used in molecular imaging for prostate cancer diagnosis, staging and monitoring
- The company also celebrates its 500th GE Healthcare cyclotron installation, a type of compact particle accelerator that produces radioisotopes fo
For media inquiries, please contact:
Margaret Steinhafel
GE Healthcare
+1 608 381 8829
[email protected]
business unit
- GE Healthcare, Medtronic receive FDA 510(k) clearance and CE Mark approval on the integration of advanced INVOS™ regional oximetry and Microstream™ capnography technologies on the CARESCAPE precision monitoring platform
- Helping providers improve patient outcomes and safety, Microstream™ capnography (CO2) technology captures evolving respiratory compromise while INVOS™ regional oximetry (rSO2) technology helps clinicians predict and prevent perioperative complications quicker than traditional peripheral measurement[i],[ii]<
For media inquiries, please contact:
Jennifer Purdue
Communications Director
GE Healthcare
+1-267-593-9735
[email protected] Tammy Hudson
Public Relations
Medtronic
+1-678-488-5337 Ryan Weispfenning
Investor Relations
Medtronic
+1-763-505-4626
business unit
- Artificial intelligence (AI) and healthcare access remain key themes at ISMRM as researchers and clinicians seek more efficient and effective solutions in today’s resource-constrained environment
- GE Healthcare highlights the continued expansion of its state-of-the-art AIR Recon DL technology across the totality of its 1.5T, 3.0T and 7.0T MR product portfolio
- Already, this democratization of AI has benefitted more than two million patients around the world and fundamentally shifted the balance between image quality and scan time in MR
For media inquiries, please contact:
Margaret Steinhafel
1 608 381 8829
[email protected]
business unit
Paris, FRANCE and Schiedam, THE NETHERLANDS – May 4, 2022 – To respond to the increasing demand for turnkey delivery of offshore high-voltage substations in the rapidly growing offshore wind market, GE’s Grid Solutions business, a global power industry systems provider, and EPCIC (turnkey) platform and modules builder HSM Offshore Energy announced today that they have signed a Memorandum of Understanding (MoU) to partner on further AC projects in Europe and beyond.
For media inquiries, please contact:
Allison J. CohenExternal Communications, Grid Solutions
GE Vernova
+972 54 7299742
[email protected] Jeanette Overvoorde
Office Manager
HSM Offshore Energy
+31 1 0427 9300
[email protected]
business unit
tags
- GE Healthcare introduces the industry’s first[i] computed tomography (CT) platform with built-in scalability and upgradability[ii]
- The new Revolution Apex platform offers the world’s fastest gantry speed: 0.23 seconds per rotation and 19.5 millisecond effective temporal resolution to freeze cardiac motion[iii]
- Altogether, the company’s CT platform enables healthcare facilities to keep up with the latest technology while minimizing technology obsolescence, optimizing clinical capabilities, and st
For media inquiries, please contact:
Margaret Steinhafel
+1 608 381 8829
[email protected]
America/Chicago
business unit
- Photon counting CT has the promise to further expand the capabilities of traditional CT
- Karolinska Institutet and MedTechLabs’ pilot study represents the first of its kind to test pure silicon CT detector technology for photon counting CT in a clinical setting
- The project is the result of close collaborations between healthcare, academia and business
Chicago, November 17, 2021: Karolinska Institutet and MedTechLabs recently started testing the world’s fir
For media inquiries, please contact:
Margaret Steinhafel1 608 381 8829
[email protected]
business unit
- Accommodates a greater variety of patients and provides a more complete look at every patient’s heart with enhanced scanning capabilities, including a 76 percent increase in field-of-view volume[i]
- Leverages GE Healthcare’s exclusive Alcyone technology, which can view cardiac anatomy and pathology with great clarity and speed
- Introduces several new automated features to help simplify workflows and expedite exams
CHICAGO – September 29, 2021 – GE Healthcare is
For media inquiries, please contact:
Margaret SteinhafelGE Healthcare
+1 608 381 8829
[email protected]
business unit
- Leverages the latest technologies to simplify processes with Effortless Workflow, a new artificial intelligence (AI) suite that reduces the number of clicks necessary to execute a CT exam by 66%[i] and helps clinicians deliver more personalized medicine – optimizing scan range settings, dose and image quality for each patient
- Accommodates a greater variety of patients with its new 75 cm wide-gantry and enhances patient comfort with 21% faster exams[ii]
- Uses a dedicated deep neural network to generate T
For media inquiries, please contact:
Margaret Steinhafel
1 608 381 8829
[email protected]
business unit
Chicago/Helsingborg, Sweden July 9, 2021: GE Healthcare announces the integration of Spectronic Medical AB AI-based software[1] for more precise cancer treatment planning. This AI solution, in combination with GE Healthcare’s industry leading AIR Recon DL technology, enables MR-only based radiotherapy planning for better soft tissue differentiation than traditional CT, so clinicians can better direct radiotherapy.
For media inquiries, please contact:
Hannah Huntly+44 7887 824201
[email protected]
Europe/London Margaret Steinhafel
+1 608 381 8829
[email protected]
America/Chicago
business unit
- GE Healthcare launches Xeleris V, a new processing and review solution that provides nuclear medicine clinicians secure access to data from anywhere, anytime
- Featuring new Artificial Intelligence-enabled (AI) applications, the solution also simplifies and enhances workflows and provides clinicians with the advanced data needed to help them make personalized care decisions and treatment recommendations that are at the heart of precision health
CHICAGO, 10 May 2021 – To help provide nuclear medicine clinicians greate
For media inquiries, please contact:
1 608 381 8829
[email protected]
business unit